Walleye Capital’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $258K | Buy |
+29,230
| New | +$258K | ﹤0.01% | 1300 |
|
|
2023
Q1 | – | Sell |
-2,939
| Closed | -$204K | – | 2479 |
|
|
2022
Q4 | $204K | Sell |
2,939
-8,112
| -73% | -$563K | ﹤0.01% | 1345 |
|
|
2022
Q3 | $1.62M | Buy |
+11,051
| New | +$1.62M | 0.03% | 530 |
|
|
2022
Q2 | – | Sell |
-8,047
| Closed | -$813K | – | 2504 |
|
|
2022
Q1 | $813K | Buy |
8,047
+7,447
| +1,241% | +$752K | 0.02% | 713 |
|
|
2021
Q4 | $93K | Buy |
+600
| New | +$93K | ﹤0.01% | 1648 |
|